The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
Stryker’s scale-building efforts have been notable over the past few years, and at $4.7bn this is its largest-ever deal.
A return to tuck-in deals – sort of.
Many small groups are up thanks to takeover speculation, and this may end up being self-defeating.